The report on the Global Viral Inactivation Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Study period considered for research of the market:
- Base Year: 2019
- Estimated Year: 2020
- Forecast Till: 2026
A glimpse of the major drivers and restraints affecting the market is mentioned below:
Drivers
- Rapid growth in pharmaceutical and biotechnology industries
- Growing number of new drug launches
- Strong R&D investments in the life sciences industry
- Growing government support for pharmaceutical and biotechnology industries
- High incidence and large economic burden of chronic diseases
Restraints
- High degree of consolidation
The report offers a value chain analysis that gives a comprehensive outlook of the market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.
This market has been segmented based on method such as solvent detergent method, pasteurization, and other viral inactivation method. The study incorporates periodic market estimates and forecasts. Each method has been analyzed based on the market size at regional and country levels.
This market has been segmented based on product such as kits and reagents, services, and viral inactivation systems and accessories. The study incorporates periodic market estimates and forecasts. Each product has been analyzed based on the market size at regional and country levels.
This market has been segmented based on applications such as blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. The report provides forecast and estimates for each application in terms of market size during the study period. Each application has been further analyzed based on regional and country levels.
This market has been segmented based on end user such as pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. The study incorporates periodic market estimates and forecasts. Each end user has been analyzed based on the market size at regional and country levels.
Geographically, this market has been segmented into regions such as North America, Europe, Asia Pacific, and Rest of the World. The study details country-level aspects based on each segment and gives estimates in terms of market size.
The report also covers the complete competitive landscape of the global Viral Inactivation market with company profiles of key players such as:
- Danaher Corporation
- Merck KGAA
- Parker Hannifin Corporation
- Sartorius AG
- SGS SA
- Charles River Laboratories International, Inc.
- Clean Cells Inc.
- Rad Source Technologies, Inc.
- Texcell, Inc.
- Viral Inactivated Plasma Systems SA
- Wuxi Pharmatech (Cayman) Inc.
A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of this market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
By Method:
- Solvent Detergent Method
- Pasteurization
- Other Viral Inactivation Method
By Product:
- Kits and Reagents
- Services
- Viral Inactivation Systems and Accessories
By Applications:
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines &Therapeutics
By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic Research Institutes
- Other End Users
By Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
The Global Viral Inactivation Market has been exhibited in detail in the following chapters -
Chapter 1 Viral Inactivation Market Preface
Chapter 2 Executive Summary
Chapter 3 Viral Inactivation Industry Analysis
Chapter 4 Viral Inactivation Market Value Chain Analysis
Chapter 5 Viral Inactivation Market Analysis By Method
Chapter 6 Viral Inactivation Market Analysis By Product
Chapter 7 Viral Inactivation Market Analysis By Applications
Chapter 8 Viral Inactivation Market Analysis By End-User
Chapter 9 Viral Inactivation Market Analysis By Geography
Chapter 10 Competitive Landscape Of Viral Inactivation Companies
Chapter 11 Company Profiles Of Viral Inactivation Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.